Supplier profile
ROCHE FARMA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 30 Jun 2008 to 7 Oct 2026.
Awards won
1,072
all time
Attributed value
€1.4bn
217 shared, unvalued
Buyers
292
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 66 | €21.3m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 51 | €27.5m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 41 | €16.4m |
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 40 | €13.4m |
| Dirección General de Planificación Económica | 27 | €36.1m |
| Osakidetza | 26 | €79.6m |
| Gerencia de Servicio Sanitarios de Fuerteventura | 21 | €4.1m |
| Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote | 20 | €6.5m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 20 | €17.7m |
| Hospital Clínico San Carlos de Madrid | 19 | €16.1m |
What they win
Awards
Showing 426–450 of 1,072 awards we hold
- Suministro por exclusividad de fármaco Emicizumab medicamento Hemlibra 150 mg/ml solución inyectable, 1 vial de 0,4 ml y Hemlibra 150 mg/ml solución inyectable, 1 vial de 1 ml con destino a las farmacias hospitalarias del área de salud de Badajoz ↗Gerencia del Área de Salud de Badajoz€293kawarded 14 Jun 2022
- Suministro de medicamentos de Roche - trastuzumab (herceptin), rituximab (mabthera), pertuzumab (perjeta), pirfenidona (esbriet), trastuzumab.emtansina (kadcycla) - Derivado del Acuerdo Marco 265/2019 HCD ↗Inspección General de Sanidad de la Defensa€192kawarded 13 Jun 2022
- TA2023 Suministro de medicamentos trastuzumab (herceptin), rituximab (mabthera), pertuzumab (perjeta), pirfenidona (esbriet), trastuzumab.emtansina (kadcycla) - Derivado del Acuerdo Marco 265/2019 HCD ↗Inspección General de Sanidad de la Defensa€240kawarded 13 Jun 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€830kawarded 10 Jun 2022
- Spain-Majadahonda: Pharmaceutical products ↗Hospital Universitario Puerta de Hierro de Majadahonda€2.6mawarded 3 Jun 2022
- Spain-Leganés: Pharmaceutical products ↗HOSPITAL UNIVERSITARIO SEVERO OCHOA (SERVICIO MADRILEÑO DE SALUD)shared awardawarded 1 Jun 2022
- Spain-Llerena: Antineoplastic agents ↗Gerencia del Área de Salud de Llerena-Zafra€330kawarded 31 May 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal€566kawarded 24 May 2022
- Spain-Las Palmas de Gran Canaria: Various medicinal products ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€220kawarded 16 May 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Pazshared awardawarded 6 May 2022
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€3.4mawarded 4 May 2022
- Spain-Granada: Pharmaceutical products ↗SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVESshared awardawarded 29 Apr 2022
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€1.6mawarded 29 Apr 2022
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€618kawarded 29 Apr 2022
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€1.7mawarded 29 Apr 2022
- Spain-Fuenlabrada: Pharmaceutical products ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€873kawarded 29 Apr 2022
- suministro del medicamento Pertuzumab 420 mg concentrado para solución para perfusión, con destino a los hospitales dependientes de la Gerencia del Área de Salud de Llerena-Zafra. ↗Gerencia del Área de Salud de Llerena-Zafra€330kawarded 27 Apr 2022
- Spain-Madrid: Pharmaceutical products ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€1.1mawarded 26 Apr 2022
- Suministro de medicamentos exclusivo de las firmas Amgen, Bristol-Myers Sauibb, Merck Sharp Dohme de España y Roche Farma, con destino a la Atención Integrada de Cuenca ↗Gerencia de Atención Integrada de Cuenca€1.1mawarded 20 Apr 2022
- Spain-Barcelona: Pharmaceutical products ↗INSTITUT CATALÀ DE LA SALUTshared awardawarded 19 Apr 2022
- Spain-Móstoles: Antineoplastic and immunomodulating agents ↗CONSEJERIA DE SANIDAD DE LA COMUNIDAD DE MADRID.-SERVICIO MADRILEÑO DE SALUD.-HOSPITAL UNIVERSITARIO DE MOSTOLESshared awardawarded 15 Apr 2022
- Spain-Jaén: Pharmaceutical products ↗SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO DE JAENshared awardawarded 15 Apr 2022
- Spain-Majadahonda: Pharmaceutical products ↗Hospital Universitario Puerta de Hierro de Majadahonda€1.5mawarded 13 Apr 2022
- Suministro del principio activo denominado Emicizumab ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€220kawarded 11 Apr 2022
- Spain-Valencia: Antineoplastic agents ↗Subsecretaría de la Consellería de Sanidad y Salud Públicashared awardawarded 6 Apr 2022
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.